Fig. 1From: B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patientsSchematic overview of the study design. PET positron emission tomography, CT computer tomographyBack to article page